ARTICLE | Financial News

Aptinyx raises $70M series B

December 18, 2017 1:16 PM UTC

Aptinyx Inc. (Evanston, Ill.) raised $70 million in an oversubscribed series B round led by new investor Bain Capital Life Sciences. New investors Adage Capital, Agent Capital, HBM Healthcare Investments, Nan Fung Life Sciences, Partner Fund Management and Rock Springs Capital also participated, along with existing investors New Leaf Venture Partners, Frazier Healthcare Partners, Longitude Capital, Osage University Partners, Adams Street Partners, LVP Life Science Ventures, PathoCapital, Goudy Park Capital, Beecken Petty O’Keefe and Northwestern University.

Bain's Adam Koppel joined Aptinyx's board...

BCIQ Company Profiles

Aptinyx Inc.

BCIQ Target Profiles

NMDA receptor